Ítem
1 juny 2018 | |
http://hdl.handle.net/2072/312276 | |
Impact Journals | |
Attribution 3.0 Spain | |
http://creativecommons.org/licenses/by/3.0/es/ | |
Cèl·lules canceroses
Mama -- Càncer Breast -- Cancer Càncer -- Tractament Cancer -- Treatment |
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts | |
info:eu-repo/semantics/article | |
Recercat |